Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
18.95
+0.19 (1.01%)
Oct 29, 2026, 10:30 AM EDT - Market open
Immunome Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $40 | Buy | Maintains | $40 | +111.08% | Oct 27, 2026 |
| Barclays | Barclays | Buy Maintains $36 | Buy | Maintains | $36 | +89.97% | Oct 27, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $35 | Buy | Maintains | $35 | +84.70% | Oct 27, 2026 |
| William Blair | William Blair | Buy Initiates $35 | Buy | Initiates | $35 | +84.70% | Oct 16, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $24 | Hold | Maintains | $24 | +26.65% | Oct 6, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $40 | Buy | Maintains | $40 | +111.08% | Oct 5, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Initiates $32 | Buy | Initiates | $32 | +68.87% | Sep 21, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $35 | Buy | Maintains | $35 | +84.70% | Aug 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.